Format

Send to

Choose Destination
Can Respir J. 2011 Sep-Oct;18(5):262-4.

A case of adalimumab-induced pneumonitis in a 45-year-old man with Crohn's disease.

Author information

1
Department of Medicine, University of British Columbia, Vancouver, British Columbia. jdreid@interchange.ubc.ca

Abstract

Adalimumab is a human monoclonal antibody against tumour necrosis factor-alpha that has been associated with acute lung toxicity, mainly in patients with rheumatoid arthritis. Descriptions of similar patterns of lung injury in patients treated with adalimumab for inflammatory bowel disease are emerging in the literature. A case involving a 45-year-old man with Crohn's disease who developed a nonbronchiolitis inflammatory nodular pattern of lung injury after starting adalimumab is reported.

PMID:
21969926
PMCID:
PMC3267602
DOI:
10.1155/2011/713821
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Hindawi Publishing Corporation Icon for PubMed Central
Loading ...
Support Center